INSURASALES

Tag: Earnings

Atlantic American Q3 Net Income Rebounds on Premium Growth and Investment Gains

Atlantic American reports Q3 net income of $0.6M, reversing prior loss with growth in premium revenue and unrealized investment gains across key insurance lines.

Kinsale Capital Posts 24% Q3 Net Income Growth on Strong Underwriting, Investment Gains

Kinsale Capital Group reports 24% net income growth in Q3, driven by robust underwriting and a 25% rise in investment income, while keeping catastrophe losses low.

Selective Insurance Misses Q3 Earnings Estimates Amid Revenue Growth

Selective Insurance reported Q3 earnings below analyst estimates despite revenue growth. Market impact and future outlook for this property and casualty insurer analyzed.

Truist Financial Sees Institutional Investment Shifts and Solid Analyst Ratings

Truist Financial experiences shifts in institutional investments amid mixed earnings and maintains a moderate buy analyst consensus with a 4.4% dividend yield. Key insights into stock performance and investor activity.

Mixed Q2 Earnings Highlight Divergent Performances Among U.S. Insurers

Explore the latest Q2 earnings results from major U.S. insurance companies, highlighting mixed performances amid evolving market dynamics and regulatory shifts.

Kansas City Life Insurance Resolves Lawsuits, Stabilizes Earnings

Kansas City Life Insurance Company resolves class action lawsuits that impeded its sale, with core earnings at $0.77 per share and projected future earnings of $3 to $4, indicating financial stabilization.

Financial Sector Leaders Barclays, Cincinnati Financial, and LendingClub Exceed Q2 Earnings Expectations

Barclays, Cincinnati Financial, and LendingClub topped Q2 earnings expectations, showing strong growth and attractive valuations in banking, insurance, and consumer lending sectors.

UnitedHealth Faces Critical Earnings as Share Price Halves Amid Sector Challenges

UnitedHealth Group's stock has fallen 50% amid sector-wide challenges and regulatory scrutiny. The upcoming earnings report and guidance will be pivotal for investor confidence.

Pediatrix Medical Group Schedules Q2 2025 Earnings Call Highlighting Operational and Compliance Strategies

Pediatrix Medical Group to report Q2 2025 results with focus on operational performance, regulatory compliance, and revenue cycle management strategies impacting healthcare insurers and providers.

Q1 Earnings Show Mixed Results for Leading U.S. Reinsurers Amid Market Cyclicality

Q1 earnings season reveals mixed financial performance among major U.S. reinsurance companies, highlighting industry cyclicality, catastrophe risk exposure, and market dynamics affecting underwriting margins and stock valuations.